(+)-catechin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of IGFBP5 mRNA CTD PMID:24763279 (1->4)-beta-D-glucan multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IGFBP5 mRNA CTD PMID:36331819 (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA CTD PMID:23859036 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases expression ISO Igfbp5 (Mus musculus) 6480464 2 more ... CTD PMID:11509743 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression EXP 6480464 2 more ... CTD PMID:19414516 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Estradiol co-treated with 2 more ... CTD PMID:11509743 1,10-phenanthroline decreases degradation EXP 6480464 1 and 10-phenanthroline results in decreased degradation of IGFBP5 protein CTD PMID:8894652 1,2-dichloroethane increases expression ISO Igfbp5 (Mus musculus) 6480464 ethylene dichloride results in increased expression of IGFBP5 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO Igfbp5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of IGFBP5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IGFBP5 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of IGFBP5 mRNA CTD PMID:30723492 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of IGFBP5 mRNA CTD PMID:22101062 17alpha-ethynylestradiol increases expression ISO Igfbp5 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of IGFBP5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Ethinyl Estradiol results in decreased expression of IGFBP5 mRNA CTD PMID:18936297 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of IGFBP5 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IGFBP5 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of IGFBP5 mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of IGFBP5 mRNA CTD PMID:32145629 17beta-estradiol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Estradiol results in decreased expression of IGFBP5 mRNA CTD PMID:15159206 more ... 17beta-estradiol affects expression ISO IGFBP5 (Homo sapiens) 6480464 Estradiol affects the expression of IGFBP5 mRNA CTD PMID:14699072 and PMID:21826169 17beta-estradiol decreases expression ISO Igfbp5 (Mus musculus) 6480464 Estradiol results in decreased expression of IGFBP5 mRNA CTD PMID:11509743 17beta-estradiol multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Estradiol co-treated with 2 more ... CTD PMID:11509743 17beta-estradiol increases expression ISO IGFBP5 (Homo sapiens) 6480464 Estradiol results in increased expression of IGFBP5 mRNA CTD PMID:17555868 and PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGFBP5 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO IGFBP5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP5 mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Igfbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP5 mRNA CTD PMID:26139165 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Igfbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP5 mRNA CTD PMID:17555868 and PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO IGFBP5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP5 mRNA CTD PMID:17555868 and PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Igfbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP5 mRNA CTD PMID:16054899 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP5 mRNA] more ... CTD PMID:16054899 and PMID:17942748 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Igfbp5 (Mus musculus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGFBP5 mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Igfbp5 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of IGFBP5 mRNA CTD PMID:17982090 and PMID:18200517 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP5 mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of IGFBP5 mRNA CTD PMID:17109745 2-methylcholine affects expression ISO IGFBP5 (Homo sapiens) 6480464 beta-methylcholine affects the expression of IGFBP5 mRNA CTD PMID:21179406 3',5'-cyclic AMP multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Igfbp5 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of IGFBP5 mRNA CTD PMID:25172293 3,3',5,5'-tetrabromobisphenol A decreases expression ISO IGFBP5 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of IGFBP5 mRNA CTD PMID:33476716 3,4-methylenedioxymethamphetamine increases expression ISO Igfbp5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of IGFBP5 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP5 mRNA more ... CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP5 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol S results in decreased expression of IGFBP5 mRNA CTD PMID:33476716 4,4'-sulfonyldiphenol increases expression ISO Igfbp5 (Mus musculus) 6480464 bisphenol S results in increased expression of IGFBP5 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Fenretinide results in decreased expression of IGFBP5 mRNA CTD PMID:16671099 4-hydroxyphenyl retinamide decreases expression ISO Igfbp5 (Mus musculus) 6480464 Fenretinide results in decreased expression of IGFBP5 mRNA CTD PMID:28973697 4-nitrophenol decreases expression ISO Igfbp5 (Mus musculus) 6480464 4-nitrophenol results in decreased expression of IGFBP5 mRNA CTD PMID:34673133 4-vinylcyclohexene dioxide affects expression ISO Igfbp5 (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of IGFBP5 mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 Decitabine inhibits the reaction [monomethylarsonous acid results in decreased expression of IGFBP5 mRNA] CTD PMID:16507463 5-fluorouracil decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of IGFBP5 mRNA CTD PMID:16557594 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of IGFBP5 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO IGFBP5 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP5 mRNA CTD PMID:20147733 and PMID:22079614 acrylamide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Acrylamide results in decreased expression of IGFBP5 mRNA CTD PMID:32763439 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of IGFBP5 mRNA CTD PMID:17109745 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP5 mRNA] CTD PMID:17109745 all-trans-retinoic acid increases expression ISO Igfbp5 (Mus musculus) 6480464 Tretinoin results in increased expression of IGFBP5 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of IGFBP5 mRNA CTD PMID:21934132 and PMID:23724009 all-trans-retinoic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of IGFBP5 mRNA CTD PMID:16443354 aluminium trifluoride increases expression ISO IGFBP5 (Homo sapiens) 6480464 aluminum fluoride results in increased expression of IGFBP5 mRNA and aluminum fluoride results in increased expression of IGFBP5 protein CTD PMID:11996908 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IGFBP5 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of IGFBP5 mRNA CTD PMID:30779732 amphotericin B decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Amphotericin B results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 antirheumatic drug increases expression ISO IGFBP5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of IGFBP5 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO IGFBP5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of IGFBP5 mRNA CTD PMID:33212167 arsane multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of IGFBP5 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of IGFBP5 mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of IGFBP5 mRNA] CTD PMID:31646340 arsenite(3-) decreases expression ISO IGFBP5 (Homo sapiens) 6480464 arsenite results in decreased expression of IGFBP5 mRNA CTD PMID:31646340 arsenous acid increases expression ISO IGFBP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of IGFBP5 protein CTD PMID:27430728 arsenous acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP5 protein CTD PMID:27430728 atrazine increases expression ISO IGFBP5 (Homo sapiens) 6480464 Atrazine results in increased expression of IGFBP5 mRNA CTD PMID:22378314 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of IGFBP5 mRNA CTD PMID:36841081 benzamidine decreases degradation EXP 6480464 benzamidine results in decreased degradation of IGFBP5 protein CTD PMID:8894652 benzo[a]pyrene decreases expression ISO Igfbp5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of IGFBP5 mRNA CTD PMID:22610609 benzo[a]pyrene increases methylation ISO IGFBP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of IGFBP5 5' UTR and Benzo(a)pyrene results in increased methylation of IGFBP5 exon CTD PMID:27901495 benzylpenicillin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Penicillin G results in decreased expression of IGFBP5 mRNA CTD PMID:24737281 beta-carotene multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA CTD PMID:23859036 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP5 mRNA] CTD PMID:17109745 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of IGFBP5 mRNA CTD PMID:17109745 bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of IGFBP5 mRNA CTD PMID:10604720 bis(2-chloroethyl) sulfide decreases expression ISO Igfbp5 (Mus musculus) 6480464 Mustard Gas results in decreased expression of IGFBP5 mRNA CTD PMID:15674843 bisphenol A affects expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol A affects the expression of IGFBP5 mRNA CTD PMID:21826169 bisphenol A increases expression ISO Igfbp5 (Mus musculus) 6480464 bisphenol A results in increased expression of IGFBP5 mRNA CTD PMID:30951980 and PMID:32156529 bisphenol A decreases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of IGFBP5 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IGFBP5 mRNA CTD PMID:25181051 more ... Bisphenol B increases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol B results in increased expression of IGFBP5 protein CTD PMID:34186270 bisphenol F decreases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol F results in decreased expression of IGFBP5 mRNA CTD PMID:33476716 bisphenol F increases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol F results in increased expression of IGFBP5 protein CTD PMID:34186270 bisphenol F increases expression ISO Igfbp5 (Mus musculus) 6480464 bisphenol F results in increased expression of IGFBP5 mRNA CTD PMID:30951980 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of IGFBP5 mRNA CTD PMID:19167457 cadmium atom decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Cadmium results in decreased expression of IGFBP5 mRNA CTD PMID:31646340 cadmium atom multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 Cadmium inhibits the reaction [Fulvestrant results in increased expression of IGFBP5 mRNA] CTD PMID:31646340 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IGFBP5 mRNA CTD PMID:15454312 calcitriol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 IGFBP5 protein inhibits the reaction [Calcitriol results in increased expression of COL1A1 protein] CTD PMID:17595320 calcium atom affects expression EXP 6480464 Calcium affects the expression of IGFBP5 mRNA CTD PMID:15913539 calcium atom decreases degradation EXP 6480464 Calcium results in decreased degradation of IGFBP5 protein CTD PMID:8894652 calcium(0) decreases degradation EXP 6480464 Calcium results in decreased degradation of IGFBP5 protein CTD PMID:8894652 calcium(0) affects expression EXP 6480464 Calcium affects the expression of IGFBP5 mRNA CTD PMID:15913539 carbamazepine affects expression ISO IGFBP5 (Homo sapiens) 6480464 Carbamazepine affects the expression of IGFBP5 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO Igfbp5 (Mus musculus) 6480464 Nanotubes and Carbon analog affects the expression of IGFBP5 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO Igfbp5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to IGFBP5 gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of IGFBP5 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of IGFBP5 mRNA CTD PMID:18668222 cisplatin decreases expression ISO Igfbp5 (Mus musculus) 6480464 Cisplatin results in decreased expression of IGFBP5 mRNA CTD PMID:21151649 cisplatin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 cisplatin affects response to substance ISO IGFBP5 (Homo sapiens) 6480464 IGFBP5 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clobetasol decreases expression ISO Igfbp5 (Mus musculus) 6480464 Clobetasol results in decreased expression of IGFBP5 mRNA CTD PMID:27462272 copper atom increases expression EXP 6480464 Copper results in increased expression of IGFBP5 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of IGFBP5 mRNA CTD PMID:30556269 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of IGFBP5 mRNA CTD PMID:15755911 cortisol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Hydrocortisone results in decreased expression of IGFBP5 mRNA CTD PMID:21267416 coumestrol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Coumestrol results in decreased expression of IGFBP5 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of IGFBP5 mRNA CTD PMID:29523930 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of IGFBP5 mRNA CTD PMID:26577399 curcumin multiple interactions ISO Igfbp5 (Mus musculus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGFBP5 mRNA] CTD PMID:18200517 curcumin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of IGFBP5 protein CTD PMID:27430728 cyclophosphamide decreases expression ISO Igfbp5 (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of IGFBP5 mRNA CTD PMID:15331540 cyclophosphamide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Cyclophosphamide results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of IGFBP5 mRNA CTD PMID:21865292 cytarabine decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Cytarabine results in decreased expression of IGFBP5 mRNA CTD PMID:21198554 dexamethasone multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP5 mRNA more ... CTD PMID:16054899 dexamethasone multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP5 mRNA CTD PMID:28628672 dexamethasone increases expression ISO IGFBP5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of IGFBP5 mRNA CTD PMID:25047013 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of IGFBP5 mRNA] CTD PMID:20032058 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of IGFBP5 mRNA CTD PMID:20032058 diarsenic trioxide increases expression ISO IGFBP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of IGFBP5 protein CTD PMID:27430728 diarsenic trioxide multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP5 protein CTD PMID:27430728 dibenz[a,h]anthracene decreases expression ISO Igfbp5 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of IGFBP5 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of IGFBP5 mRNA CTD PMID:15829613 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of IGFBP5 mRNA CTD PMID:37077353 dimethylarsinous acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 dimethylarsinous acid results in decreased expression of IGFBP5 mRNA CTD PMID:16507463 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IGFBP5 mRNA CTD PMID:33729688 diquat decreases expression ISO Igfbp5 (Mus musculus) 6480464 Diquat results in decreased expression of IGFBP5 mRNA CTD PMID:36851058 disodium selenite multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA CTD PMID:23859036 diuron decreases expression EXP 6480464 Diuron results in decreased expression of IGFBP5 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO Igfbp5 (Mus musculus) 6480464 Doxorubicin results in decreased expression of IGFBP5 protein CTD PMID:30517846 doxorubicin increases expression ISO IGFBP5 (Homo sapiens) 6480464 Doxorubicin results in increased expression of IGFBP5 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of IGFBP5 mRNA CTD PMID:30031762 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of IGFBP5 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA CTD PMID:19167446 entinostat multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGFBP5 mRNA CTD PMID:27188386 entinostat decreases expression ISO IGFBP5 (Homo sapiens) 6480464 entinostat results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 estriol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Estriol results in decreased expression of IGFBP5 mRNA CTD PMID:15159206 ethanol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of IGFBP5 mRNA CTD PMID:23378141 ethanol increases expression ISO Igfbp5 (Mus musculus) 6480464 Ethanol results in increased expression of IGFBP5 mRNA CTD PMID:30319688 ethanol affects splicing ISO Igfbp5 (Mus musculus) 6480464 Ethanol affects the splicing of IGFBP5 mRNA CTD PMID:30319688 ethanol increases expression ISO IGFBP5 (Homo sapiens) 6480464 Ethanol results in increased expression of IGFBP5 mRNA CTD PMID:23378141 ethylenediaminetetraacetic acid decreases degradation EXP 6480464 Edetic Acid results in decreased degradation of IGFBP5 protein CTD PMID:8894652 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of IGFBP5 mRNA CTD PMID:18035473 fluvastatin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of IGFBP5 mRNA CTD PMID:16996129 folic acid affects expression ISO IGFBP5 (Homo sapiens) 6480464 Folic Acid affects the expression of IGFBP5 mRNA CTD PMID:17320366 folic acid multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IGFBP5 mRNA CTD PMID:22206623 folic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of IGFBP5 mRNA CTD PMID:23378141 formaldehyde increases expression ISO IGFBP5 (Homo sapiens) 6480464 Formaldehyde results in increased expression of IGFBP5 mRNA CTD PMID:28937961 fulvestrant increases expression ISO IGFBP5 (Homo sapiens) 6480464 Fulvestrant results in increased expression of IGFBP5 mRNA CTD PMID:31646340 fulvestrant multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of IGFBP5 mRNA] more ... CTD PMID:31646340 genistein decreases expression EXP 6480464 Genistein results in decreased expression of IGFBP5 mRNA CTD PMID:22504913 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of IGFBP5 mRNA CTD PMID:22061828 and PMID:33387578 gentamycin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Gentamicins results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 hydrazines decreases expression ISO Igfbp5 (Mus musculus) 6480464 Hydrazines results in decreased expression of IGFBP5 mRNA CTD PMID:21647536 hydrogen peroxide increases expression ISO IGFBP5 (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of IGFBP5 mRNA CTD PMID:12414654 and PMID:32949572 Indeno[1,2,3-cd]pyrene decreases expression ISO Igfbp5 (Mus musculus) 6480464 indeno(1 more ... CTD PMID:26377693 indometacin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP5 mRNA CTD PMID:28628672 irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of IGFBP5 mRNA CTD PMID:20097248 iron dichloride decreases expression ISO IGFBP5 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of IGFBP5 mRNA CTD PMID:35984750 isoflavones affects expression ISO IGFBP5 (Homo sapiens) 6480464 Isoflavones affects the expression of IGFBP5 mRNA CTD PMID:16365062 isotretinoin increases expression ISO IGFBP5 (Homo sapiens) 6480464 Isotretinoin results in increased expression of IGFBP5 mRNA CTD PMID:20436886 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of IGFBP5 mRNA CTD PMID:36653537 and PMID:37077353 L-ascorbic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of IGFBP5 mRNA CTD PMID:16443354 L-ascorbic acid multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA CTD PMID:23859036 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of IGFBP5 mRNA CTD PMID:11578147 linuron decreases expression EXP 6480464 Linuron results in decreased expression of IGFBP5 mRNA CTD PMID:12730624 lipopolysaccharide multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of IGFBP5 mRNA CTD PMID:28801915 medroxyprogesterone acetate decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in decreased expression of IGFBP5 mRNA CTD PMID:20843944 menadione increases expression ISO IGFBP5 (Homo sapiens) 6480464 Vitamin K 3 results in increased expression of IGFBP5 mRNA CTD PMID:12414654 mercury dibromide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 metacetamol decreases expression ISO Igfbp5 (Mus musculus) 6480464 3-hydroxyacetanilide results in decreased expression of IGFBP5 mRNA CTD PMID:18544908 methamphetamine multiple interactions EXP 6480464 IGFBP5 mutant form inhibits the reaction [Methamphetamine results in increased activity of CASP3 protein] and IGFBP5 mutant form inhibits the reaction [Methamphetamine results in increased activity of PARP1 protein] CTD PMID:25127757 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of IGFBP5 mRNA and Methamphetamine results in increased expression of IGFBP5 protein CTD PMID:25127757 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of IGFBP5 mRNA CTD PMID:15120968 methoxychlor multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Estradiol co-treated with Methoxychlor metabolite] results in decreased expression of IGFBP5 mRNA CTD PMID:11509743 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of IGFBP5 mRNA CTD PMID:23303685 methoxychlor decreases expression ISO Igfbp5 (Mus musculus) 6480464 Methoxychlor metabolite results in decreased expression of IGFBP5 mRNA CTD PMID:11509743 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of IGFBP5 mRNA CTD PMID:28349193 methylmercury chloride decreases expression ISO IGFBP5 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of IGFBP5 mRNA CTD PMID:28001369 mifepristone decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Mifepristone results in decreased expression of IGFBP5 mRNA CTD PMID:17584828 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of IGFBP5 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO IGFBP5 (Homo sapiens) 6480464 Diethylnitrosamine results in increased expression of IGFBP5 mRNA CTD PMID:21527772 N-nitrosodiethylamine decreases expression ISO Igfbp5 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of IGFBP5 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of IGFBP5 mRNA CTD PMID:17032414 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of IGFBP5 mRNA and nitrofen results in decreased expression of IGFBP5 protein CTD PMID:19844724 Nonylphenol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 nonylphenol results in decreased expression of IGFBP5 mRNA CTD PMID:15159206 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of IGFBP5 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of IGFBP5 mRNA CTD PMID:25729387 ozone multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of IGFBP5 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGFBP5 mRNA CTD PMID:27188386 p-menthan-3-ol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Menthol results in decreased expression of IGFBP5 mRNA CTD PMID:26760959 paracetamol decreases expression ISO Igfbp5 (Mus musculus) 6480464 Acetaminophen results in decreased expression of IGFBP5 mRNA CTD PMID:18544908 paraquat increases expression EXP 6480464 Paraquat results in increased expression of IGFBP5 mRNA CTD PMID:18198484 pentane-2,3-dione decreases expression EXP 6480464 2 and 3-pentanedione results in decreased expression of IGFBP5 mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IGFBP5 mRNA CTD PMID:36331819 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of IGFBP5 mRNA CTD PMID:31324951 phenobarbital affects expression ISO Igfbp5 (Mus musculus) 6480464 Phenobarbital affects the expression of IGFBP5 mRNA CTD PMID:23091169 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of IGFBP5 mRNA CTD PMID:18158353 phenylmethanesulfonyl fluoride decreases degradation EXP 6480464 Phenylmethylsulfonyl Fluoride results in decreased degradation of IGFBP5 protein CTD PMID:8894652 phorbol 13-acetate 12-myristate multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP5 mRNA CTD PMID:16979875 pirinixic acid multiple interactions ISO Igfbp5 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of IGFBP5 mRNA] CTD PMID:20059764 pirinixic acid decreases expression ISO Igfbp5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of IGFBP5 mRNA CTD PMID:20059764 and PMID:23811191 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of IGFBP5 mRNA CTD PMID:12832660 potassium dichromate increases expression ISO Igfbp5 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of IGFBP5 mRNA CTD PMID:23608068 progesterone multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of IGFBP5 mRNA CTD PMID:20660070 progesterone decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Progesterone results in decreased expression of IGFBP5 mRNA CTD PMID:18070364 and PMID:20864642 propiconazole decreases expression ISO Igfbp5 (Mus musculus) 6480464 propiconazole results in decreased expression of IGFBP5 mRNA CTD PMID:21278054 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of IGFBP5 mRNA CTD PMID:19228061 resveratrol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of IGFBP5 mRNA CTD PMID:19167446 resveratrol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 resveratrol results in decreased expression of IGFBP5 mRNA CTD PMID:15280659 rimonabant multiple interactions ISO Igfbp5 (Mus musculus) 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of IGFBP5 mRNA] CTD PMID:19030233 rimonabant affects expression ISO Igfbp5 (Mus musculus) 6480464 Rimonabant affects the expression of IGFBP5 mRNA CTD PMID:19030233 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of IGFBP5 mRNA CTD PMID:27979718 and PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO IGFBP5 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of IGFBP5 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of IGFBP5 mRNA CTD PMID:25895662 silver atom decreases expression ISO Igfbp5 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP5 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Igfbp5 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP5 mRNA CTD PMID:27131904 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of IGFBP5 mRNA CTD PMID:21865292 sodium arsenate multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of IGFBP5 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO IGFBP5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of IGFBP5 mRNA CTD PMID:16507463 more ... sodium arsenite decreases expression ISO Igfbp5 (Mus musculus) 6480464 sodium arsenite results in decreased expression of IGFBP5 mRNA CTD PMID:17451858 sodium arsenite increases expression ISO Igfbp5 (Mus musculus) 6480464 sodium arsenite results in increased expression of IGFBP5 mRNA CTD PMID:17077188 sodium arsenite affects expression ISO Igfbp5 (Mus musculus) 6480464 sodium arsenite affects the expression of IGFBP5 mRNA CTD PMID:16507464 sodium arsenite increases methylation ISO IGFBP5 (Homo sapiens) 6480464 sodium arsenite results in increased methylation of IGFBP5 gene CTD PMID:24570342 Soman increases expression EXP 6480464 Soman results in increased expression of IGFBP5 mRNA CTD PMID:19281266 succimer multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP5 mRNA CTD PMID:26378955 sunitinib decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Sunitinib results in decreased expression of IGFBP5 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of IGFBP5 mRNA CTD PMID:21865292 tamoxifen affects expression ISO IGFBP5 (Homo sapiens) 6480464 Tamoxifen affects the expression of IGFBP5 mRNA CTD PMID:14699072 tamoxifen increases response to substance ISO IGFBP5 (Homo sapiens) 6480464 IGFBP5 protein results in increased susceptibility to Tamoxifen CTD PMID:20354179 temozolomide increases expression ISO IGFBP5 (Homo sapiens) 6480464 Temozolomide results in increased expression of IGFBP5 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO IGFBP5 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of IGFBP5 mRNA CTD PMID:12414654 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of IGFBP5 mRNA] CTD PMID:20032058 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of IGFBP5 mRNA CTD PMID:17032414 tetraphene decreases expression ISO Igfbp5 (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of IGFBP5 mRNA CTD PMID:26377693 thapsigargin increases expression ISO IGFBP5 (Homo sapiens) 6480464 Thapsigargin results in increased expression of IGFBP5 mRNA CTD PMID:22378314 thapsigargin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of IGFBP5 mRNA CTD PMID:29453283 theophylline decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Theophylline results in decreased expression of IGFBP5 mRNA CTD PMID:16083514 thimerosal decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Thimerosal results in decreased expression of IGFBP5 mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IGFBP5 mRNA CTD PMID:34492290 Thiorphan affects expression ISO IGFBP5 (Homo sapiens) 6480464 Thiorphan affects the expression of IGFBP5 protein CTD PMID:16405511 titanium dioxide affects expression ISO Igfbp5 (Mus musculus) 6480464 titanium dioxide affects the expression of IGFBP5 mRNA CTD PMID:23557971 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of IGFBP5 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of IGFBP5 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of IGFBP5 gene CTD PMID:27618143 trichostatin A increases expression ISO IGFBP5 (Homo sapiens) 6480464 trichostatin A results in increased expression of IGFBP5 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGFBP5 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO IGFBP5 (Homo sapiens) 6480464 trichostatin A results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 triclosan increases expression ISO IGFBP5 (Homo sapiens) 6480464 Triclosan results in increased expression of IGFBP5 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO Igfbp5 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of IGFBP5 mRNA CTD PMID:19042947 triptonide decreases expression ISO Igfbp5 (Mus musculus) 6480464 triptonide results in decreased expression of IGFBP5 mRNA CTD PMID:33045310 troglitazone increases expression ISO IGFBP5 (Homo sapiens) 6480464 troglitazone results in increased expression of IGFBP5 mRNA CTD PMID:19140230 troglitazone decreases expression ISO Igfbp5 (Mus musculus) 6480464 troglitazone results in decreased expression of IGFBP5 mRNA CTD PMID:28973697 tunicamycin increases expression ISO IGFBP5 (Homo sapiens) 6480464 Tunicamycin results in increased expression of IGFBP5 mRNA CTD PMID:22378314 valproic acid decreases methylation ISO IGFBP5 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of IGFBP5 gene CTD PMID:29154799 valproic acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of IGFBP5 mRNA CTD PMID:28001369 valproic acid affects expression ISO IGFBP5 (Homo sapiens) 6480464 Valproic Acid affects the expression of IGFBP5 mRNA CTD PMID:25979313 valproic acid increases expression ISO IGFBP5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of IGFBP5 mRNA CTD PMID:24935251 vanadium atom increases expression ISO IGFBP5 (Homo sapiens) 6480464 Vanadium results in increased expression of IGFBP5 mRNA CTD PMID:19000753 vanadium(0) increases expression ISO IGFBP5 (Homo sapiens) 6480464 Vanadium results in increased expression of IGFBP5 mRNA CTD PMID:19000753 vancomycin increases expression ISO Igfbp5 (Mus musculus) 6480464 Vancomycin results in increased expression of IGFBP5 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of IGFBP5 mRNA CTD PMID:18042343 and PMID:30207508 vorinostat decreases expression ISO IGFBP5 (Homo sapiens) 6480464 vorinostat results in decreased expression of IGFBP5 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP5 mRNA CTD PMID:16979875 zinc atom multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA CTD PMID:23859036 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP5 mRNA CTD PMID:20128680 zinc atom decreases degradation EXP 6480464 Zinc results in decreased degradation of IGFBP5 protein CTD PMID:8894652 zinc(0) multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP5 mRNA CTD PMID:16979875 zinc(0) decreases degradation EXP 6480464 Zinc results in decreased degradation of IGFBP5 protein CTD PMID:8894652 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP5 mRNA CTD PMID:20128680 zinc(0) multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA CTD PMID:23859036 zoledronic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of IGFBP5 mRNA CTD PMID:16996129